Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN).
Takuma KatoRyuji MatsumotoAkira YokomizoYoichiro TohiHiroshi FukuharaYoichi FujiiKeiichiro MoriTakuma SatoJunichi InokuchiKatsuyoshi HashineShinichi SakamotoHidefumi KinoshitaKoji InoueToshiki TanikawaTakanobu UtsumiTakayuki GotoIsao HaraHiroshi OkunoYoshiyuki KakehiMikio SugimotoPublished in: BJU international (2024)
Pathological reclassification was observed in approximately 30% of the patients during biopsy; however, biopsy acceptance rates decreased over time. Although metastasis occurred in six patients, only one death from prostate cancer was recorded.